PE Deals

L Catterton completes take-private buyout of vitamin maker Thorne HealthTech

An earlier news item on the deal pegged the purchase price to be about $680 million or $10.20 per share

-
  • As a result of the closing, Thorne HealthTech will no longer trade on the NASDAQ
  • BofA Securities served as financial advisor and Kirkland & Ellis LLP served as legal advisor to L Catterton
  • L Catterton invests in the consumer sector

L Catterton has closed its previously announced take-private buyout of U.S.

Share this